Page 6 - Shanghai Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shanghai pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shanghai Pharma Today - Breaking & Trending Today

China's MediTrust Health raises $155m from Ant, Sinovation, others


streetAsia s premium
subscription service
Unlock your competitive advantage in a
rapidly evolving landscape. Our packages
come with exclusive access to archive
content, data, discount on summit tickets & more.
Be a part of our growing community now.
SUBSCRIBE NOW
Singapore Reporter/s
In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We ....

Xiaodong Zhang , Ant Group , Meditrust Health , Shanghai Biopharmaceutical Investment Fund , Sinovation Ventures , Huaxing Growth Capital , Northern Light Venture Capital , Biotrack Capital , Marathon Venture Partners , Shanghai Pharma , எறும்பு குழு , வடக்கு ஒளி துணிகர மூலதனம் , மராத்தான் துணிகர கூட்டாளர்கள் , ஷாங்காய் பார்மா ,

Chinese online pharmacy SPH gathers $159.7m in Series B round


Chinese online pharmacy SPH gathers $159.7m in Series B round
Visual from Shanghai Pharmaceuticals website.
February 18, 2021
SPH Health Commerce, a Chinese Internet hospital and online pharmacy, has completed its Series B round of financing at 1.033 billion yuan ($159.7 million).
With this, the company will not be a controlled subsidiary of the country’s drug developer and distributor Shanghai Pharmaceuticals.
Shanghai-based SPH, which was founded in March 2015 by Shanghai Pharma, saw the stake held by the parent reduce to nearly 48% from 72.7% after the transaction, SPH announced in a statement on Thursday.
The billion-yuan investment was completed on January 18. As a result of the new financing, Hong Kong and Shanghai-listed Shanghai Pharma will no longer consolidate the financials of SPH into its financial statements. ....

Hong Kong , Shanghai Pharmaceuticals , Shanghai Charity Foundation , Shanghai Biomedical Industrial Equity Investment Fund , Valliance Capital , Sph Health Commerce , Shanghai International Group , Chinese Internet , Shanghai Pharma , Shanghai Listed Pharma , Shanghai City , China Jianyin , New Alliance Capital , Ample Harvest Finance , Xinte Pharmaceutical Chain , Cardinal China , Cardinal Health , Softbank China Venture Capital , ஹாங் காங் , ஷாங்காய் மருந்துகள் , ஷாங்காய் தொண்டு அடித்தளம் , ஷாங்காய் உயிர் மருத்துவ தொழில்துறை பங்கு முதலீடு நிதி , கூட்டணி மூலதனம் , ஷாங்காய் சர்வதேச குழு , சீன இணையதளம் , ஷாங்காய் பார்மா ,